Estimate Recalculated Sep 9, 2024 12:33AM EST
Apeiron Investment Group Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alto Neuroscience, Inc., ATAI Life Sciences N.V., and Sensei Biotherapeutics, Inc..
Apeiron Investment Group Ltd.'s CIK is 0001845711
2024 was Apeiron Investment Group Ltd.'s most active year for acquiring shares with 1 total transactions. Apeiron Investment Group Ltd.'s most active month to acquire stocks was the month of January. 2024 was Apeiron Investment Group Ltd.'s most active year for disposing of shares, totalling 2 transactions. Apeiron Investment Group Ltd.'s most active month to dispose stocks was the month of January. 2024 saw Apeiron Investment Group Ltd. paying a total of $0.00 for 251,881 shares, this is the most they've acquired in one year. In 2024 Apeiron Investment Group Ltd. cashed out on 850,633 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!